Match Document Document Title
US20050255155 Modified release cilostazol compositions  
Pharmaceutical composition comprising a therapeutically effective amount of micronized particles of cilostazol or pharmaceutically acceptable salts or esters thereof, wherein at least about 50% of...
US20060280787 Pharmaceutical formulation of the tubulin inhibitor indibulin for oral administration with improved pharmacokinetic properties, and process for the manufacture thereof  
The present invention relates to a pharmaceutical formulation for oral administration of the poorly soluble and therefore hardly bioavailable microtubule polymerization inhibitor Indibulin and a...
US20060233872 Pharmaceutical product which is used to reduced or stop moderate or severe snoring  
The invention relates to the novel use of a pharmaceutical product which combines domperidone and pseudoephedrine sulphate substances and which can be used to reduce or stop moderate or severe...
US20080254116 Delta and Epsilon Crystal Forms of Imatinib Mesylate  
The invention relates to the delta and epsilon crystal form of the methanesulfonic acid addition salt of...
US20140199380 PHARMACEUTICAL COMPOSITION COMPRISING AN ALGAE ADAPTED TO INCREASE THE EFFICACY OF AN ENZYMATIC INHIBITOR  
A pharmaceutical composition comprising at least one algae, wherein said algae is adapted to increase the efficacy of an enzymatic inhibitor.
US20150004224 DPA-ENRICHED COMPOSITIONS OF OMEGA-3 POLYUNSATURATED FATTY ACIDS IN FREE ACID FORM  
DPA-enriched pharmaceutical compositions of polyunsaturated fatty acids in free acid form, therapeutic methods for their use, and processes for refining the compositions from fish oil are...
US20070092560 Lipophilic Vehicle-Based Dual Controlled Release Matrix System  
A lipophilic vehicle-based dual controlled-release matrix, suitable for encapsulation in hard or soft capsules, has been developed. The matrix is in the form of a suspension, which allows for...
US20120207822 COMPOSITIONS AND METHODS FOR TREATMENT OF CARDIOVASCULAR DISEASE  
Provided herein are compositions for the treatment and/or prevention of cardiovascular disease (CVD), and methods of application and use thereof. In particular, the present invention provides...
US20070184102 LATEX OR PSEUDOLATEX COMPOSITIONS, COATINGS AND COATING PROCESSES  
A composition comprising: (i) at least one latex or pseudolatex water insoluble film former, (ii) at least one permeation enhancing agent and, optionally, (iii) one or more plasticizers. The...
US20140212482 MULTI-PHASE, MULTI-COMPARTMENT, CAPSULAR DELIVERY APPARATUS AND METHODS FOR USING SAME  
A multi-compartment capsule, comprising, a first receiving chamber comprising at least one ingredient having a first physical state, wherein said ingredient is selected from the group consisting...
US20130136791 MULTI-PHASE, MULT-COMPARTMENT CAPSULAR DELIVERY APPARATUS AND METHODS FOR USING SAME  
A multi-compartment capsule, comprising, a first receiving chamber comprising at least one ingredient having a first physical state, wherein said ingredient is selected from the group consisting...
US20120315313 LIQUID-FILLED CHITOSAN-ANIONIC LIPOSOLUBLE SURFACTANT CAPSULE DISPERSIONS  
The present invention generally relates to the field of membranes. In particular, the present invention relates to a composition comprising bodies surrounded by a membrane. The composition are for...
US20150064243 PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS FOR ADMININISTRATION OF HYDROPHOBIC DRUGS  
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs are provided. The pharmaceutical compositions include a therapeutically effective amount of a hydrophobic drug,...
US20060159663 Growth factor encapsulation system for enhancing bone formation  
This invention provides articles of manufacture, compositions of matter and methods related to a growth factor encapsulation system for enhancing bone formation.
US20050112189 Hard capsules  
The present invention is directed to a hard capsule filled with a solution containing an active ingredient, wherein the shell of the capsule is made of a material containing a cellulose...
US20050208124 Drugs containing riboflavin-type compounds  
A medicament is provided containing as an active ingredient at least one of riboflavin, a riboflavin derivative or a pharmacologically acceptable salt thereof, which has the action of suppressing...
US20110064798 SUSPENSION CONTAINING HYDRONIUM STABILIZED COLLOIDAL SILICIC ACID NANOPARTICLES, FORMULATION OBTAINED FROM THE SAID DILUTESUSPENSION, POWDER OBTAINED FROM THE SAID DE-HYDRATED SUSPENSION, COMPOSITIONS OBTAINED FROM THE SAID POWDER, PREPARATION AND USE  
The present invention relates to hydronium stabilized silicic acid nanoparticles, to the formulation obtained from the said diluted suspension, to the powder obtained from the said dehydrated...
US20070003612 Capsule  
A capsule 1 is adapted to be ingestable by a human or an animal and comprises a location determining device 3 for determining the capsule's 1 location following ingestion.
US20130183381 METHODS FOR TREATING MULTIPLE MYELOMA USING 4-(AMINO)-2-(2,6-DIOXO(3-PIPERIDYL))-ISOINDOLINE-1,3-DIONE IN COMBINATION WITH PROTEASOME INHIBITOR  
Methods of treating, preventing and/or managing cancer as well as and diseases and disorders associated with, or characterized by, undesired angiogenesis are disclosed. Specific methods encompass...
US20120244214 METHODS FOR TREATING MULTIPLE MYELOMA USING 3-(4-AMINO-1-OXO-1,3-DIHYDROISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE IN COMBINATION WITH PROTEASOME INHIBITOR  
Methods of treating, preventing and/or managing cancer as well as and diseases and disorders associated with, or characterized by, undesired angiogenesis are disclosed. Specific methods encompass...
US20140242163 AMANTADINE COMPOSITIONS AND METHODS OF USE  
Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine...
US20090175934 Extended Release Pharmaceutical Formulation of Venlafaxine and Method of Manufacturing the Same  
Disclosed herein is an extended release pharmaceutical formulation suitable for once daily administration, comprising a highly water soluble core consisting essentially of about 30 to about 40% by...
US20100260834 ABUSE-DETERRENT DRUG FORMULATIONS  
An abuse-deterrent pharmaceutical composition has been developed to reduce the likelihood of improper administration of drugs, especially drugs such as opiods. In the preferred embodiment, the...
US20070128271 FORMULATION AND MANUFACTURING PROCESS FOR CALCIUM ACETATE CAPSULES  
The present invention relates to a pharmaceutical calcium acetate formulation and a process for making the same. In particular, the present invention relates to a calcium acetate capsule...
US20080113018 Encapsulation Method for Compounds  
A method of providing capsules having a hydrogel shell and an oily interior and encapsulating a volatile, water-soluble substance, comprising the steps of (i) providing blank capsules having a...
US20060051408 Microcapsules for stabilization of cosmetic, pharmaceutical or food products  
Microcapsules for stabilisation of cosmetic, pharmaceutical or food products, of a size smaller than 500 μm, comprising a nucleus of an adsorbent material—natural or modified polysaccharide...
US20120177705 COMPOSITION 064  
A pharmaceutical composition which comprises N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-y l]phenyl)pyridine-3-sulphonamide with mannitol and/or microcrystalline cellulose is described.
US20150164814 APPARATUS AND PROCESS FOR ENCAPSULATING CAPSULES OR OTHER SOLID DOSAGE FORMS WITHIN CAPSULES  
The present invention provides an apparatus and process for making softgel capsules having incorporated therein other solid dosage forms selected from the group consisting of pellets, smaller...
US20120052118 Apparatus and process for encapsulating capsules or other solid dosage forms within capsules  
The present invention provides an apparatus and process for making softgel capsules having incorporated therein other solid dosage forms selected from the group consisting of pellets, smaller...
US20080138403 PHARMACEUTICAL DOSAGE FORMS OF OXCARBAZEPINE  
A pharmaceutical dosage form comprising a mixture of a therapeutically effective amount of oxcarbazepine having median particle size ranging from about 15 μm to about 26 μm and one or more...
US20070224260 Dosage Form Having Polymorphic Stability  
Mini-tablets comprising a drug substance are formed by compression, using forces sufficiently low to preserve the polymorphic form of the drug. The mini-tablets can be administered directly,...
US20120009254 Respiratory Syncytial Virus Antigenic Compositions and Methods  
Multilayer films comprise polypeptide epitopes from RSV. The multilayer films are capable of eliciting an immune response in a host upon administration to the host. The multilayer films include at...
US20100266682 POLYETHYLENE GLYCOL-COATED SODIUM CARBONATE AS A PHARMACEUTICAL EXCIPIENT AND COMPOSITIONS PRODUCED FROM THE SAME  
Non-effervescent pharmaceutical compositions having at least one particle of carbonate coated by a layer of polyethylene glycol that substantially covers the at least one carbonate particle are...
US20080206320 COMPOSITION COMPRISING AT LEAST ONE 15-PGDH INHIBITOR  
The invention relates to a cosmetic composition containing at least one 15-hydroxy-prostaglandin dehydrogenase inhibitor and cosmetically acceptable excipients. It also relates to a method of...
US20100233252 Low-Moisture-Content Hard Capsule and Production Method Therefor  
A method is provided for the production of hard capsules having a low moisture content and low hygroscopicity, as well as a method for reducing the moisture content and hygroscopicity of hard...
US20120321685 COMPOSITIONS CONTAINING OILS HAVING A SPECIFIC GRAVITY HIGHER THAN THE SPECIFIC GRAVITY OF WATER  
The invention relates to pharmaceutical or cosmetic compositions preferably in the form of microcapsules or microparticles which include at least one active ingredient and an oil or a mixture of...
US20100226976 ENCAPSULATED MESENCHYMAL STEM CELLS AND USES THEREOF  
Provided is a composition-of-matter comprising a microcapsule encapsulating mesenchymal stem cells, wherein at least 97% of cells in said microcapsule are said mesenchymal stem cells. Also...
US20080268035 Cationic Polymer Nanoparticles Encapsulating An Active Ingredients, And The Cosmetic Composition Containing The Same  
Disclosed herein are cationic polymer nanocapsules encapsulating an oil-soluble active ingredient, and a cosmetic composition containing the same. The cationic polymer nanocapsules have a...
US20050118256 Extended release alpha-2 agonist pharmaceutical dosage forms  
Disclosed is an extended release pharmaceutical formulation containing at least an alpha-2 adrenergic agonist, such as tizanidine, for the treatment and prevention of spasticity in a subject,...
US20120237595 METHODS FOR TREATING AMYLOIDOSIS USING 4-(AMINO)-2-(2,6-DIOXO(3-PIPERIDYL))- ISOINDOLINE-1,3-DIONE  
Methods of treating, preventing and/or managing cancer as well as and diseases and disorders associated with, or characterized by, undesired angiogenesis are disclosed. Specific methods encompass...
US20070141139 COMPOSITION FOR INTESTINAL DELIVERY  
The present invention relates to a new composition, use and method for oral administration to a human or an animal of a physiologically active agent comprising neutralizing agents to increase pH...
US20070172522 Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound  
Disclosed is a method for stabilizing a pharmaceutically active bi-cyclic compound of formula (i): comprising the step of: admixing the same with a polyol and/or a fatty acid ester other than...
US20060251713 Amino acid sequences capable of facilitating penetration across a biological barrier  
This invention relates to novel pharmaceutical penetration compositions capable of facilitating penetration of at least one effector across biological barriers. The invention also relates to...
US20120308651 SALTS OF BENZIMIDAZOLYL PYRIDYL ETHERS AND FORMULATIONS THEREOF  
Salts of benzimidazolyl pyridyl ethers are provided, particularly salts of {1-methyl-5-[2-(5-trifluoromethyl-1H-imidazol-2-yl)-pyridin- 4-yloxy]-1H-benzoimidazol-2-yl}-(4-trifluoromethyl-phenyl)am ...
US20080089933 Device and method for reducing calorie intake  
Devices and methods for substantially reducing the caloric efficiency of the digestive tract by capturing food being digested in the stomach 10 and/or anywhere else in the gastrointestinal (GI)...
US20140044781 Pharmaceutical Compositions Of Carvedilol Salts And Process For Preparation Thereof  
The present invention relates provides pharmaceutical compositions comprising an amorphous carvedilol salt and one or more pharmaceutically acceptable excipients, wherein the amorphous carvedilol...
US20080233182 ORGANIC COMPOUNDS  
The present invention relates to a method of protecting copper-sensitive compounds and/or compositions from decomposition.
US20130177627 Growth inhibitory effects of nanoparticles containing triterpene glycosides or triterpenes  
The present invention relates to pharmaceutical composition containing a physiologically effective dose of a nanoparticle triterpene glycoside or nanoparticle triterpene complex, wherein said...
US20130315990 DISIALYLLACTO-N-TETRAOSE (DSLNT) OR VARIANTS, ISOMERS, ANALOGS AND DERIVATIVES THEREOF TO PREVENT OR INHIBIT BOWEL DISEASE  
The invention provides formulations comprising isolated Disialyllacto-N-tetraose (DSLNT) or variants, isomers, analogs and derivatives thereof.
US20130115280 PHARMACEUTICAL AND/OR DIETARY COMPOSITIONS BASED ON SORT CHAIN FATTY ACIDS  
Pharmaceutical and/or dietary compositions based on short chain fatty acids or salts, esters and/or amides thereof in combination with one or more dietary soluble or water-dispersible fibre and at...